MA41168A - Nouveaux composés antibactériens - Google Patents
Nouveaux composés antibactériensInfo
- Publication number
- MA41168A MA41168A MA041168A MA41168A MA41168A MA 41168 A MA41168 A MA 41168A MA 041168 A MA041168 A MA 041168A MA 41168 A MA41168 A MA 41168A MA 41168 A MA41168 A MA 41168A
- Authority
- MA
- Morocco
- Prior art keywords
- antibacterial compounds
- new antibacterial
- new
- compounds
- antibacterial
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14198412 | 2014-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41168A true MA41168A (fr) | 2017-10-24 |
Family
ID=52347083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041168A MA41168A (fr) | 2014-12-17 | 2015-12-10 | Nouveaux composés antibactériens |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10369130B2 (fr) |
| EP (1) | EP3233826A1 (fr) |
| JP (1) | JP2017537938A (fr) |
| AR (1) | AR103028A1 (fr) |
| MA (1) | MA41168A (fr) |
| WO (1) | WO2016096631A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| DK3468975T3 (da) | 2016-06-08 | 2020-07-13 | Acraf | Nye antibakterielle forbindelser |
| WO2021133751A1 (fr) | 2019-12-23 | 2021-07-01 | Bristol-Myers Squibb Company | Composés quinazolinyle substitués utiles en tant qu'activateurs de lymphocytes t |
| MX2022007130A (es) * | 2019-12-23 | 2022-07-11 | Bristol Myers Squibb Co | Derivados de piperazina sustituidos utiles como activadores de celulas t. |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2637591B1 (fr) * | 1988-10-11 | 1992-10-23 | Synthelabo | Derives de quinoleinone, leur preparation et leur application en therapeutique |
| FR2655988B1 (fr) | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
| IL101722A (en) * | 1991-05-02 | 1996-05-14 | Wyeth John & Brother Ltd | Piperazine derivatives their preparation and pharmaceutical compositions containing them |
| IL105716A0 (en) * | 1992-06-08 | 1993-09-22 | Richter Gedeon Vegyeszet | Aminopropanol derivatives,their preparation and pharmaceutical compositions containing them |
| HU215397B (hu) * | 1994-08-29 | 1998-12-28 | Richter Gedeon Vegyészeti Gyár Rt. | (Piperidino-alkil)-aril-éterek, ezeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására |
| WO1998010568A1 (fr) | 1996-09-09 | 1998-03-12 | Aironet Wireless Communications, Inc. | Systeme de telecommunications cellulaires a parametres de transmission de donnees modifies de façon dynamique |
| FR2761071B1 (fr) * | 1997-03-20 | 1999-12-03 | Synthelabo | Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique |
| DE19900544A1 (de) * | 1999-01-11 | 2000-07-13 | Basf Ag | Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie |
| FR2822154B1 (fr) | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
| AU2003243497A1 (en) * | 2002-06-12 | 2003-12-31 | Millennium Pharmaceuticals, Inc. | Antagonists of melanin concentrating hormone receptor |
| TW200507841A (en) * | 2003-03-27 | 2005-03-01 | Glaxo Group Ltd | Antibacterial agents |
| WO2005082887A1 (fr) * | 2004-02-26 | 2005-09-09 | Aska Pharmaceutical Co., Ltd. | Dérivé de pyrimidine |
| WO2006003150A1 (fr) * | 2004-06-30 | 2006-01-12 | Janssen Pharmaceutica N.V. | Derives de 2-alkyl quinazolinone substitues en tant qu'inhibiteurs de parp |
| DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| WO2006046552A1 (fr) * | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | Nouveaux composés hétérocycliques azotés et sels desdits composés |
| US20090238761A1 (en) * | 2005-01-03 | 2009-09-24 | Universita Degli Studi Di Siena | Novel Aryl Piperazine Derivatives With Medical Utility |
| EP1846411A4 (fr) | 2005-01-25 | 2010-08-04 | Glaxo Group Ltd | Agents antibacteriens |
| MX2007010076A (es) * | 2005-02-17 | 2007-10-16 | Astellas Pharma Inc | Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo. |
| WO2006090272A1 (fr) * | 2005-02-22 | 2006-08-31 | Warner-Lambert Company Llc | Isoquinoline [1,8]naphthyridin-2-ones et composes relatifs destines au traitement de la schizophrenie |
| JP2009507791A (ja) * | 2005-08-29 | 2009-02-26 | メルク エンド カムパニー インコーポレーテッド | ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法 |
| WO2007070173A2 (fr) * | 2005-10-31 | 2007-06-21 | Merck & Co., Inc. | Inhibiteurs de la cetp |
| EP1903038A1 (fr) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | Dérivés N-(1-hetaryl-piperidine-4-yl)-(het)arylamide utilisées comme modulateurs du recepteur EP2 |
| EP1903037A1 (fr) * | 2006-09-07 | 2008-03-26 | Bayer Schering Pharma Aktiengesellschaft | Dérivés de 1-[(hétéro)aryl]-3-[hétéroaryl-pipéridine-4-yl]thiourée en tant que modulateurs de récepteurs EP2 |
| CL2008001002A1 (es) | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
| ATE474889T1 (de) | 2007-05-11 | 2010-08-15 | Coatex Sas | Use of a reverse emulsion of an acrylamide polymer with an acrylic monomer as a stabilising agent and foam reducer, in a method for the grinding of mineral materials and binders in an aqueous medium. |
| WO2010081874A1 (fr) | 2009-01-15 | 2010-07-22 | Glaxo Group Limited | Composés naphthyridine-2(1h)-one utiles comme antibactériens |
| CA2750047A1 (fr) * | 2009-01-21 | 2010-07-29 | Basilea Pharmaceutica Ag | Nouveaux antibiotiques bicycliques |
| WO2011057110A1 (fr) | 2009-11-06 | 2011-05-12 | Ruprecht-Karls-Universitat-Heidelberg | Agonistes de gpr109a pour le traitement de l'ischémie cérébrale |
| WO2012003418A2 (fr) | 2010-07-02 | 2012-01-05 | The University Of North Carolina At Chapel Hill | Ligands fonctionnellement sélectifs des récepteurs d2 de dopamine |
| JP6030146B2 (ja) | 2011-11-08 | 2016-11-24 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ２−オキソ−オキサゾリジン−３，５−ジイル抗生物質誘導体 |
| EP2785721A1 (fr) | 2011-11-30 | 2014-10-08 | Actelion Pharmaceuticals Ltd. | Antibiotiques d'octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one 3,7-disubstituée |
| WO2014079154A1 (fr) * | 2012-11-26 | 2014-05-30 | 辽宁贝雷生物制药有限公司 | Hétérocycles azotés pentagonaux de type pipéridine ou dérivés de pipérazine, leur procédé de préparation et composition pharmaceutique les contenant |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
-
2015
- 2015-12-10 MA MA041168A patent/MA41168A/fr unknown
- 2015-12-11 JP JP2017531401A patent/JP2017537938A/ja not_active Ceased
- 2015-12-11 US US15/534,874 patent/US10369130B2/en not_active Expired - Fee Related
- 2015-12-11 EP EP15808202.4A patent/EP3233826A1/fr not_active Withdrawn
- 2015-12-11 WO PCT/EP2015/079352 patent/WO2016096631A1/fr not_active Ceased
- 2015-12-15 AR ARP150104085A patent/AR103028A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10369130B2 (en) | 2019-08-06 |
| EP3233826A1 (fr) | 2017-10-25 |
| AR103028A1 (es) | 2017-04-12 |
| JP2017537938A (ja) | 2017-12-21 |
| US20170368017A1 (en) | 2017-12-28 |
| WO2016096631A1 (fr) | 2016-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44050A (fr) | Nouveaux composés | |
| MA42293A (fr) | Composés antibactériens | |
| MA44233A (fr) | Nouveaux composés | |
| ME03419B (fr) | Composés dihydroisoquinolinone substitués | |
| LT3197883T (lt) | Nauji junginiai | |
| LT3134402T (lt) | 4-amino-imidazochinolino junginiai | |
| EP3334584A4 (fr) | Extrudeuse | |
| PT3298027T (pt) | Compostos depsipéptidos antelmínticos | |
| MA45221A (fr) | Nouveaux composés antibactériens | |
| DK3157926T3 (da) | Organiske forbindelser | |
| EP3464336A4 (fr) | Composés | |
| EP3288600C0 (fr) | Nanofibres antibactériennes | |
| BR112016030730A2 (pt) | Composto | |
| LT3362444T (lt) | Junginiai | |
| CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
| BR112017014839A2 (pt) | novos microbicidas | |
| DK3597189T3 (da) | Krystallinske forbindelser | |
| ME03312B (fr) | Pyroglutamate de vortioxetine | |
| DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
| BR112016018442A2 (pt) | agentes antibacterianos | |
| MA49522A (fr) | Nouveaux composés de quinoléinone | |
| EP3259254A4 (fr) | Composés thérapeutiques | |
| HUE039805T2 (hu) | Új szulfonilaminobenzamid vegyületek | |
| DK3347403T3 (da) | Polyalkoxyfedtforbindelse | |
| LT3331885T (lt) | Junginiai |